Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04274686 · ClinicalTrials.gov registry record · NA

Tegarderm® Placement for Bag Mask Ventilation in the Bearded Patient

A NA study, sponsored by University of New Mexico.

Terminated
Registry status
NA
Development phase
25
Enrollment target

NCT04274686: Clinical Trial NA study, sponsored by University of New Mexico.

NCT04274686 is a NA study that was terminated before completion, run by University of New Mexico. The registered enrollment target is 25 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04274686, a NA study, was terminated before completion, sponsored by University of New Mexico.

TERMINATED
Registry status
NA
Development phase
25 participants
Enrollment target

Study Summary

Difficult Bag Mask Ventilation is well described in the anesthesiology literature, and bearded patients are likely to experience this phenomenon. This study involves application of a large and perforated Tegaderm® across the lower face of the bearded patient to quantify its effectiveness at improving mask ventilation in this anesthetized population.

Primary Outcome

Leakage defined as difference in inspired and expired tidal volumes during bag-mask ventilation, as a percentage of inspired tidal volume.

Interventions

  • DEVICE Tegaderm placement
  • OTHER No Tegaderm

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2020-02-12
Est. Completion 2021-05-03
Phase NA
University of New Mexico

168 total trials

Why NCT04274686 stopped before completion

NCT04274686 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 2 interventions - of which Tegaderm placement is the first listed.

NCT04274686 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04274686 about?

NCT04274686 is a clinical study titled "Tegarderm® Placement for Bag Mask Ventilation in the Bearded Patient". Difficult Bag Mask Ventilation is well described in the anesthesiology literature, and bearded patients are likely to experience this phenomenon. This study involves application of a large and perforated Tegaderm® across the lower face of the bearded patient to quantify its effectiveness at improvin...

What is the current status of trial NCT04274686?

This trial is currently terminated. It is a NA study. The enrollment target is 25 participants. The study started on 2020-02-12. Estimated completion is 2021-05-03.

What interventions are being tested in trial NCT04274686?

The interventions under investigation include: Tegaderm placement (DEVICE), No Tegaderm (OTHER).

Who is sponsoring clinical trial NCT04274686?

This trial is sponsored by University of New Mexico, which has 168 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04274686's enrollment target sits among peer trials

25 1712th of 2000 higher than 265 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01166854 · 25 participants

    Characterization of Familial Myopathy and Paget Disease of Bone

  • NCT01913106 · 25 participants · Phase 1

    HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer

  • NCT02138669 · 25 participants · NA

    Intacs Prescription Inserts for Keratoconus Patients

  • NCT02174549 · 25 participants · Phase 1

    Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04274686, the US trial registry maintained by the National Library of Medicine. NCT04274686 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.